// App-Quantinova.ai

e22056 : Monitoring of circulating tumor DNA in metastatic triple-negative breast cancer patients undergoing chemotherapy.

Researchers

Presenter

  • Jordan Madic

Principal Investigators

  • Francois-Clement Bidard

  • Nicolas Giroud

  • Roland Schmucki

  • Carsten Horn

  • Olivia Spleiss

  • Olivier Lantz

  • Marc-Henri Stern

  • Jean-Yves Pierga

  • Martin Weisser

  • Emilie Vinolo

  • Quentin Leroy

  • Thomas Rio-Frio

  • Virginie Bernard

  • Alban Lermine

  • Inga Clausen

  • Ronald Lebofsky

  • Fabian Birzele

  • Guillemette Ramey

Medical Centers

  • Institut Curie, Paris Cedex, France

  • Roche Pharma Research and Early Development (pRED), Penzberg, GermanyInstitut Roche de Recherche et Medecine Translationnelle, Boulogne-Billancourt, FranceRoche Pharma Research and Early Development (pRED), Basel, Switzerland

Locations

  • France

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Roche

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved